Contact
Please use this form to send email to PR contact of this press release:
Personalized Stem Cells Announces Brazilian Approval for COVID-19 Clinical Trial Licensed to Sorrento Therapeutics
TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+1 833-772-3557